Oncology & Cancer

Cell-weighing method could help doctors choose cancer drugs

Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Oncology & Cancer

Anti-myeloma agent opens for new treatment strategy

The tumour form multiple myeloma is very challenging to treat and is still considered incurable. In a recently published study in the scientific journal Oncotarget, researchers at Uppsala University show how inhibition of ...

Oncology & Cancer

A first: All respond to gene therapy in a blood cancer study

Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that's on the rise. Although it's early and the study is small—35 people—every patient responded and all ...

Oncology & Cancer

CAR T-Cell therapy sends multiple myeloma into lasting remission

In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of immunotherapy ? chimeric antigen receptor (CAR) T cells targeting B-cell maturation protein or ...

Oncology & Cancer

Researchers ID drug that blocks some blood cancers

A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS. Their research, published May 15 in the Journal of Clinical Investigation, also demonstrates ...

page 2 from 15